Alyeska Investment Group
MDLN

Alyeska Investment Group’s Medline Inc MDLN Stock Holding History

Alyeska Investment Group’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$131M Buy
2,937,389
+1,737,389
+145% +$76.7M 0.37% 65
2025
Q4 		$50.4M Buy
+1,200,000
New +$50.7M 0.14% 181

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Alyeska Investment Group's MDLN Position: Q1 2026 in Review

Alyeska Investment Group increased its Medline Inc (MDLN) stake by 145% in Q1 2026, buying an estimated $76.7M and bringing the position to 2,937,389 shares worth $131M. The position accounts for 0.37% of the portfolio, ranked #65.

Alyeska Investment Group first reported a position in MDLN in Q4 2025 and has held it in 2 quarters since. 314 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Alyeska Investment Group held 2,937,389 shares of Medline Inc worth $131M as of Q1 2026.
  • Alyeska Investment Group bought 1,737,389 Medline Inc shares in Q1 2026, an estimated $76.7M.
  • Medline Inc made up 0.37% of Alyeska Investment Group's portfolio in Q1 2026, its #65 holding.
  • Alyeska Investment Group first reported a position in Medline Inc in Q4 2025 and has held it in 2 quarters since.
  • 314 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.